You have 9 free searches left this month | for more free features.

PREMIERE

Showing 1 - 25 of 206

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Heart Transplantation Trial in Paris (Heart transplantation)

Not yet recruiting
  • Heart Transplantation
  • Heart transplantation
  • Paris, France
    Pitié-Salpêtrière Hospital
Sep 11, 2023

Renal Impairment Trial in United States (S-1/Cisplatin)

Completed
  • Renal Impairment
  • Scottsdale, Arizona
  • +8 more
Sep 27, 2022

Solid Tumor Trial in United States (ASP3082)

Recruiting
  • Solid Tumor
  • Santa Monica, California
  • +10 more
Jan 6, 2023

Dry Eye Disease Trial in Lakeway (K-161, Placebo)

Recruiting
  • Dry Eye Disease
  • Birmingham, Alabama
  • +50 more
Jan 17, 2023

Cancer Trial in United States (mAb RAV12)

Completed
  • Cancer
  • monoclonal antibody RAV12
  • Santa Monica, California
  • +4 more
Feb 4, 2022

Migraine in Children, Migraine Trial in United States (Eptinezumab)

Active, not recruiting
  • Migraine in Children
  • Migraine
  • Stamford, Connecticut
  • +8 more
Nov 14, 2022

Parkinson Disease Dementia, Dementia With Lewy Bodies Trial in United States (ATH-1017, Placebo)

Recruiting
  • Parkinson Disease Dementia
  • Dementia With Lewy Bodies
  • Boca Raton, Florida
  • +9 more
May 17, 2022

Alzheimer, Dementia of Alzheimer Type Trial in Australia, United States (ATH-1017, Placebo)

Completed
  • Alzheimer Disease
  • Dementia of Alzheimer Type
  • Santa Ana, California
  • +12 more
Jul 5, 2022

Dry Eye Disease Trial in United States (AR 15512 Ophthalmic Solution, Vehicle)

Recruiting
  • Dry Eye Disease
  • Torrance, California
  • +19 more
Dec 9, 2022

a High Probability of Meeting Eligibility Criteria

Recruiting
  • Alzheimer Disease
  • +4 more
  • Prescreener database
  • San Diego, California
  • +18 more
Dec 28, 2022

COVID-19 Trial in Worldwide (ABO1020, Placebo)

Recruiting
  • COVID-19
  • ABO1020
  • Placebo
  • Depok, Indonesia
  • +27 more
Dec 15, 2022

Migraine Trial in United States (AMG 334 Dose 1, AMG 334 Dose 2, AMG 334 Dose 3)

Terminated
  • Migraine
  • AMG 334 Dose 1
  • +2 more
  • Little Rock, Arkansas
  • +13 more
Feb 10, 2022

Parkinson Disease Psychosis Trial in United States (Pimavanserin)

Completed
  • Parkinson Disease Psychosis
  • Scottsdale, Arizona
  • +17 more
Aug 31, 2022

Atopic Keratoconjunctivitis Trial in United States (Dupilumab)

Recruiting
  • Atopic Keratoconjunctivitis
  • Los Angeles, California
  • +12 more
Nov 23, 2021

Contact Lens Complication, Debris in Post Lens Tear Reservoir Trial in West Linn (Saline Solution Enriched, Saline Rinse

Completed
  • Contact Lens Complication
  • Debris in Post Lens Tear Reservoir
  • Saline Solution Enriched
  • Saline Rinse Solution
  • West Linn, Oregon
    Andre Vision and Device Research
Jan 25, 2021

Parkinson Disease, Constipation Trial in United States (Active Investigational Treatment ENT-01)

Completed
  • Parkinson Disease
  • Constipation
  • Active Investigational Treatment ENT-01
  • Fountain Valley, California
  • +17 more
Mar 21, 2022

Type 2 Diabetes Trial in Worldwide (Orforglipron, Placebo)

Not yet recruiting
  • Type 2 Diabetes
  • Chandler, Arizona
  • +34 more
Oct 26, 2023

Covid-19 Cases Occurred In A Lymphoma Setting In The First

Completed
  • COVID
  • Lymphoma
    • Le Chesnay, France
      CH de Versailles
    Aug 6, 2020

    Open-angle Glaucoma, Ocular Hypertension Trial in Japan, United States (AGN-193408 SR, Lumigan, Sham Administration)

    Recruiting
    • Open-angle Glaucoma
    • Ocular Hypertension
    • AGN-193408 SR
    • +3 more
    • Inglewood, California
    • +27 more
    Oct 4, 2022

    EEG/ERP Longitudinal Study in Alzheimer's Disease (AD)

    Completed
    • Alzheimer's Disease
    • ERP/EEG test
    • Psychometric testing
    • West Palm Beach, Florida
    • +2 more
    Feb 25, 2020

    A Study of Brain Aging in Vietnam War Veterans

    Completed
    • Traumatic Brain Injury
    • +3 more
      • Sun City, Arizona
      • +18 more
      Nov 24, 2021

      Type 2 Diabetes, Chronic Kidney Disease Trial in United States (CTP-499, Placebo)

      Completed
      • Type 2 Diabetes Mellitus
      • Chronic Kidney Disease
      • Tempe, Arizona
      • +48 more
      Aug 6, 2021

      Ocular Inflammation and Pain After Cataract Surgery Trial in United States (APP13007, 0.05%, Matching Vehicle Placebo for

      Recruiting
      • Ocular Inflammation and Pain After Cataract Surgery
      • APP13007, 0.05%
      • Matching Vehicle Placebo for APP13007, 0.05%
      • Mesa, Arizona
      • +31 more
      Mar 15, 2022

      Alzheimer Trial in Australia, United States (ATH-1017)

      Enrolling by invitation
      • Alzheimer Disease
      • Sun City, Arizona
      • +35 more
      Feb 28, 2022